---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-031647"
form_type: "8-K"
ticker: "ICCC"
cik: "0000811641"
company_name: "IMMUCELL CORP /DE/"
filed_at: "2024-04-09T23:59:59+00:00"
generated_at: "2026-06-04T01:13:21.837305+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ImmuCell enters ATM offering agreement for up to $11M common stock with Craig-Hallum

## Summary
- Company entered into ATM offering agreement with Craig-Hallum for up to $11M of common stock.
- Craig-Hallum will receive 3.0% commission on gross proceeds from sales.
- Company amended FAME loan agreement to remove restrictions on equity issuance.
- Offering is under effective shelf registration statement (S-3) filed April 1, 2024.

## SEC filing metadata
- accession: 0001213900-24-031647
- form_type: 8-K
- ticker: ICCC
- cik: 0000811641
- company_name: IMMUCELL CORP /DE/
- filed_at: 2024-04-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/811641/000121390024031647/0001213900-24-031647-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/811641/000121390024031647/ea0203573-8k_immucell.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-031647
- JSON: https://secwatch.observer/filing/0001213900-24-031647.json
- Plain text: https://secwatch.observer/filing/0001213900-24-031647.txt

## Key facts
- Material Agreements
  IMMUCELL CORP /DE/ amended First Amendment to Economic Recovery Loan Program Loan Agreement with Finance Authority of Maine valued at amends the FAME Loan Agreement to remove any restrictions on the Company’s ability to issue equity s (effective 2024-04-08).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Finance Authority of Maine
  - Value: amends the FAME Loan Agreement to remove any restrictions on the Company’s ability to issue equity s
  - Effective: 2024-04-08
  source text: In connection with entering into the Sales Agreement, on April 8, 2024, the Company entered into an amendment (the "First Amendment") to the Company's Economic Recovery Loan Program Loan Agreement, by and between the Company and the Finance Authority of Maine dated July 17, 2023 (the "FAME Loan Agreement").
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000121390024031647/0001213900-24-031647-index.htm
- Material Agreements
  IMMUCELL CORP /DE/ entered into At The Market Offering Agreement with Craig-Hallum Capital Group LLC valued at up to $11,000,000 of shares of common stock (effective 2024-04-09).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Craig-Hallum Capital Group LLC
  - Value: up to $11,000,000 of shares of common stock
  - Effective: 2024-04-09
  source text: On April 9, 2024, ImmuCell Corporation (the “Company”) entered into an At The Market Offering Agreement (the “Sales Agreement”) with Craig-Hallum Capital Group LLC (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agent, up to $11,000,000 of shares of its common stock, par value $0.10 per share (the “Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/811641/000121390024031647/0001213900-24-031647-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.